Axispharm offers you high-purity endo-BCN-Val-cit-PAB-MMAE, a synthetic antibody-drug conjugate conjugated to a BCN group containing a protease-sensitive Val-Cit dipeptide and an MMAE payload . MMAE is a synthetic antineoplastic agent that attaches to monoclonal antibodies (MABs) and directs them to cancer cells. The BCN group can react with azide-labeled compounds or biomolecules.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.